ProPhase Labs (PRPH) Set to Announce Quarterly Earnings on Thursday

ProPhase Labs (NASDAQ:PRPH) is set to announce its earnings results before the market opens on Thursday, May 9th. Analysts expect the company to announce earnings of ($0.28) per share for the quarter. Investors interested in registering for the company’s conference call can do so using this link.

ProPhase Labs (NASDAQ:PRPH) last issued its quarterly earnings data on Thursday, March 28th. The company reported ($0.51) earnings per share for the quarter. ProPhase Labs had a negative return on equity of 29.83% and a negative net margin of 37.81%. The business had revenue of $3.50 million for the quarter, compared to analysts’ expectations of $10.71 million. On average, analysts expect ProPhase Labs to post $-1 EPS for the current fiscal year and $0 EPS for the next fiscal year.

ProPhase Labs Price Performance

Shares of PRPH traded down $0.14 during mid-day trading on Tuesday, reaching $5.20. 5,119 shares of the company’s stock were exchanged, compared to its average volume of 44,791. The company has a quick ratio of 2.10, a current ratio of 2.28 and a debt-to-equity ratio of 0.29. The company has a 50-day simple moving average of $5.54 and a two-hundred day simple moving average of $5.04. ProPhase Labs has a 52-week low of $4.05 and a 52-week high of $9.94. The company has a market cap of $93.86 million, a price-to-earnings ratio of -5.45 and a beta of -0.17.

Analyst Upgrades and Downgrades

Separately, HC Wainwright reissued a “buy” rating and set a $11.00 price objective on shares of ProPhase Labs in a research note on Wednesday, February 21st.

About ProPhase Labs

ProPhase Labs, Inc develops and commercializes novel drugs, dietary supplements, and compounds in the United States. It operates through two segments: Diagnostic Services and Consumer Products. The company provides a range of TK supplements, including Legendz XL for male sexual health; and Triple Edge XL, an energy and stamina booster.